Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AERC Stock Summary
In the News
10:34 16 Mar 2023 AERC
Why Is AeroClean (AERC) Stock Up 37% Today?
Source: Shutterstock.com AeroClean (NASDAQ: AERC ) stock is gaining on Tuesday after the company revealed merger plans with Molekule to create a major player in the air purification market. AeroClean and Molekule are planning for an all-stock transaction that will result in a combined company.
06:00 16 Mar 2023 AERC
Hot Penny Stocks to Buy Today? 3 to Watch Right Now
What you need to know about trading penny stocks today The post Hot Penny Stocks to Buy Today? 3 to Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
12:05 16 Mar 2023 AERC
MICS, AERC: 5 Top Short Squeeze Stocks to Watch
With a new week comes all of the latest short-squeeze stocks that investors are going to want to keep an eye on and we've got a list to help! The post MICS, AERC: 5 Top Short Squeeze Stocks to Watch appeared first on InvestorPlace.
10:42 16 Mar 2023 AERC
3 Penny Stocks That Turned $1,000 Into Over $9,300 This Quarter
Penny stocks that hit it big in Q2 & June 2022 The post 3 Penny Stocks That Turned $1,000 Into Over $9,300 This Quarter appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
03:59 16 Mar 2023 AERC
Benchmark Downgrades AeroClean After Share Price Rallies
Benchmarkanalyst Robert Wasserman downgradedAeroClean Technologies Inc(NASDAQ: AERC)to Hold from Buy, without a price target. The analyst notes that despite a poor overall market outlook, the company's shares have quickly reached and exceeded earlier price targets.
04:11 16 Mar 2023 AERC
Why AeroClean Technologies Stock Is Soaring
AeroClean TechnologiesInc (NASDAQ: AERC) shares are trading significantly higher Tuesday on continued momentum after the U.S. Food and Drug Administrationgranted clearance for the company's Pūrgo technology, classifying it as a class II medical device. AeroClean's Pūrgo device.
10:42 16 Mar 2023 AERC
AERC Stock Is in the Spotlight After AeroClean Receives FDA Clearance
Yesterday, the FDA designated AeroClean'sair purification system as a "Class II Medical Device," this sent AERC stock soaring. The post AERC Stock Is in the Spotlight After AeroClean Receives FDA Clearance appeared first on InvestorPlace.
04:07 16 Mar 2023 AERC
Best Penny Stocks to Buy That Exploded Today? 3 to Watch
Check these penny stocks out for your watchlist right now The post Best Penny Stocks to Buy That Exploded Today? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
02:27 16 Mar 2023 AERC
The Mysterious and Baffling Cautionary Tale of AeroClean Technologies
AERC stock is a bit of a mystery, but likely some form of pump and dump. That's all we really know after it spiked and quickly tanked.
01:09 16 Mar 2023 AERC
Assessing AeroClean's Odds After its Sudden Crash
AeroClean soared tenfold following a tiny IPO. However, AERC stock subsequently crashed.
AERC Financial details
Company Rating
Strong Buy
Market Cap
52.69M
Income
-2.84M
Revenue
491.25K
Book val./share
1.54
Cash/share
1.68
Dividend
-
Dividend %
-
Employees
7
Shortable
Yes
Earnings
31 Mar 2022
P/E
-18.4
Forward P/E
-
PEG
-14.72
P/S
106.43
P/B
2.21
P/C
2.02
P/FCF
-
Quick Ratio
9.6
Current Ratio
10.2
Debt / Equity
0.25
LT Debt / Equity
-
-
-
EPS (TTM)
-0.27
EPS next Y
-
EPS next Q
-
EPS this Y
138.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-17.67%
EPS Q/Q
-216.22%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-10%
ROE
-14%
ROC
-0.54%
Gross Margin
47%
Oper. Margin
-2937%
Profit Margin
-579%
Payout
-
Shs Outstand
15.5M
Shs Float
7.18M
-
-
-
-
Target Price
-
52W Range
1.76-23.7
52W High
-85.22%
52W Low
+240%
RSI
47
Rel Volume
0.27
Avg Volume
236.29K
Volume
63.61K
Perf Week
17.24%
Perf Month
4.94%
Perf Quarter
-
Perf Half Y
-11.92%
-
-
-
-
Beta
-
-
-
Volatility
0.2%, 0.19%
Prev Close
18.47%
Price
3.4
Change
19.72%
AERC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|
Revenue per share | 0 | 0 | 0.04 | |
Net income per share | -0.01 | -0.24 | -0.57 | |
Operating cash flow per share | -0.01 | -0.22 | -0.5 | |
Free cash flow per share | -0.01 | -0.25 | -0.5 | |
Cash per share | 0 | 0.17 | 1.42 | |
Book value per share | -0.02 | 0.18 | 1.57 | |
Tangible book value per share | -0.02 | 0.18 | 1.57 | |
Share holders equity per share | -0.02 | 0.18 | 1.57 | |
Interest debt per share | 0 | 0 | 0 | |
Market cap | 1.09B | 1.09B | 145.15M | |
Enterprise value | 1.09B | 1.09B | 125.52M | |
P/E ratio | -7.17K | -329.33 | -18.32 | |
Price to sales ratio | 0 | 0 | 235.44 | |
POCF ratio | -11.44K | -356.48 | -20.81 | |
PFCF ratio | -11.44K | -310.5 | -20.81 | |
P/B Ratio | -4.75K | 432.93 | 6.69 | |
PTB ratio | -4.75K | 432.93 | 6.69 | |
EV to sales | 0 | 0 | 203.6 | |
Enterprise value over EBITDA | -7.17K | -328.63 | -15.37 | |
EV to operating cash flow | -11.44K | -355.72 | -18 | |
EV to free cash flow | -11.44K | -309.84 | -18 | |
Earnings yield | 0 | 0 | -0.05 | |
Free cash flow yield | 0 | 0 | -0.05 | |
Debt to equity | -1 | 0.26 | 0.09 | |
Debt to assets | 290.74 | 0.21 | 0.08 | |
Net debt to EBITDA | 0.01 | 0.7 | 2.4 | |
Current ratio | 0 | 4.12 | 14.28 | |
Interest coverage | 0 | 0 | 0 | |
Income quality | 0.63 | 0.92 | 0.88 | |
Dividend Yield | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 6.8 | |
Intangibles to total assets | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.15 | 0.25 | |
Capex to revenue | 0 | 0 | -2.84 | |
Capex to depreciation | 0 | 0 | -21.95 | |
Stock based compensation to revenue | 0 | 0 | 1.93 | |
Graham number | 0.06 | 0.99 | 4.49 | |
ROIC | 0.66 | -1.31 | -0.37 | |
Return on tangible assets | -191.86 | -1.04 | -0.33 | |
Graham Net | -0.02 | 0.13 | 1.3 | |
Working capital | -230.63K | 2.07M | 20.07M | |
Tangible asset value | -230.63K | 2.53M | 21.71M | |
Net current asset value | -230.63K | 2.07M | 19.57M | |
Invested capital | 0 | 0 | 0 | |
Average receivables | 0 | 50.27K | 138.8K | |
Average payables | 0 | 238.4K | 629.63K | |
Average inventory | 0 | 0 | 322.97K | |
Days sales outstanding | 0 | 0 | 104.83 | |
Days payables outstanding | 0 | 0 | 998.61 | |
Days of inventory on hand | 0 | 0 | 695.7 | |
Receivables turnover | 0 | 0 | 3.48 | |
Payables turnover | 0 | 0 | 0.37 | |
Inventory turnover | 0 | 0 | 0.52 | |
ROE | 0.66 | -1.31 | -0.36 | |
Capex per share | 0 | -0.03 | -0.13 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 0.02 | 0.03 | 0 | 0.01 | 0 | |
Net income per share | -0.11 | -0.14 | -0.19 | -0.37 | 0.43 | |
Operating cash flow per share | -0.11 | -0.42 | -0.13 | -0.18 | -0.19 | |
Free cash flow per share | -0.12 | -0.53 | -0.13 | -0.19 | -0.19 | |
Cash per share | 0.05 | 1.6 | 1.28 | 2.1 | 1.68 | |
Book value per share | 0.17 | 1.77 | 1.43 | 1.17 | 1.54 | |
Tangible book value per share | 0.17 | 1.77 | 1.43 | 1.17 | 1.54 | |
Share holders equity per share | 0.17 | 1.77 | 1.43 | 1.17 | 1.54 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 1.09B | 128.13M | 49.96M | 182.01M | 44.44M | |
Enterprise value | 1.09B | 108.5M | 32.19M | 152.85M | 18.62M | |
P/E ratio | -179.06 | -18.4 | -4.84 | -8.8 | 1.67 | |
Price to sales ratio | 4.19K | 360.72 | 7.42K | 2.57K | 761.18 | |
POCF ratio | -695.55 | -25.08 | -27.34 | -73.24 | -15.22 | |
PFCF ratio | -677.76 | -19.86 | -26.92 | -69.7 | -15.21 | |
P/B Ratio | 467.06 | 5.9 | 2.52 | 11.2 | 1.88 | |
PTB ratio | 467.06 | 5.9 | 2.52 | 11.2 | 1.88 | |
EV to sales | 4.19K | 305.46 | 4.78K | 2.16K | 318.96 | |
Enterprise value over EBITDA | -732.99 | -78.77 | -12.21 | -29.04 | 2.87 | |
EV to operating cash flow | -695.14 | -21.24 | -17.61 | -61.5 | -6.38 | |
EV to free cash flow | -677.35 | -16.82 | -17.35 | -58.54 | -6.37 | |
Earnings yield | 0 | -0.01 | -0.05 | -0.03 | 0.15 | |
Free cash flow yield | 0 | -0.05 | -0.04 | -0.01 | -0.07 | |
Debt to equity | 0.91 | 0.09 | 0.08 | 1.03 | 0.25 | |
Debt to assets | 0.48 | 0.08 | 0.08 | 0.51 | 0.2 | |
Net debt to EBITDA | 0.44 | 14.25 | 6.75 | 5.54 | -3.98 | |
Current ratio | 0.58 | 14.28 | 15.49 | 17.3 | 10.2 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.03 | 2.93 | 0.71 | 0.48 | -0.44 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 2.62 | 0 | 318.17 | 0 | 0 | |
Research and developement to revenue | 3.66 | 1.62 | 78.94 | 8.17 | 10.85 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.03 | 0.33 | 0.02 | 0.05 | 0 | |
Capex to revenue | -0.16 | -4.81 | -4.17 | -1.78 | -0.04 | |
Capex to depreciation | -1.15 | -38.97 | -0.78 | -3.48 | -0.06 | |
Stock based compensation to revenue | 0 | 3.34 | 99.63 | 9.99 | 13.6 | |
Graham number | 0.65 | 2.38 | 2.44 | 3.13 | 3.87 | |
ROIC | -0.65 | -0.09 | -0.13 | -0.15 | -0.19 | |
Return on tangible assets | -0.34 | -0.07 | -0.12 | -0.16 | 0.22 | |
Graham Net | -0.09 | 1.48 | 1.19 | 0.93 | 1.34 | |
Working capital | -902.69K | 20.07M | 18.07M | 28.95M | 24.74M | |
Tangible asset value | 2.34M | 21.71M | 19.8M | 16.25M | 23.69M | |
Net current asset value | -902.69K | 19.57M | 17.67M | 14.02M | 21.51M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 100.9K | 189.43K | 91.63K | 17.12K | 19.97K | |
Average payables | 698.85K | 848.47K | 681.78K | 562.07K | 771.03K | |
Average inventory | 226.5K | 446.49K | 682.35K | 861.73K | 1.16M | |
Days sales outstanding | 69.51 | 44.86 | 82.69 | 35.6 | 18.33 | |
Days payables outstanding | 468.93 | 436.53 | 10.43K | 1.71K | 2.49K | |
Days of inventory on hand | 150.5 | 304.11 | 17.19K | 2.5K | 3.82K | |
Receivables turnover | 1.29 | 2.01 | 1.09 | 2.53 | 4.91 | |
Payables turnover | 0.19 | 0.21 | 0.01 | 0.05 | 0.04 | |
Inventory turnover | 0.6 | 0.3 | 0.01 | 0.04 | 0.02 | |
ROE | -0.65 | -0.08 | -0.13 | -0.32 | 0.28 | |
Capex per share | 0 | -0.14 | 0 | -0.01 | 0 |
AERC Frequently Asked Questions
What is AeroClean Technologies, Inc. stock symbol ?
AeroClean Technologies, Inc. is a US stock , located in Palm beach gardens of Fl and trading under the symbol AERC
What is AeroClean Technologies, Inc. stock quote today ?
AeroClean Technologies, Inc. stock price is $3.4 today.
Is AeroClean Technologies, Inc. stock public?
Yes, AeroClean Technologies, Inc. is a publicly traded company.
Something similar
Top by Market Cap
EMBASSY.NS
BRK-B
MSFT
AAPL
ABEC.DE
Same Sector
AIR.DE
HON
8001.T
SIX2.DE
0NHS.L
Same Price Range
ORDI.AS
NILAINFRA.NS
0797.HK
000069.SZ
RSI
Similar Market Cap
8028.HK
WRAP
JEQ
FACO
TSL.L
Company Profile
IndustrialsPollution & Treatment Controls
- Volume Average 236.29K
- Market Capitalization 52.69M
- Employee 7
- CEO Dr. Amin J. Khoury Ph.D.
- Headquarters Palm Beach Gardens,FL,US
- IPO Date 2021-11-24
-
Website https://aeroclean.com
AeroClean Technologies, Inc., an interior space air purification technology company, provides air purification solutions for hospitals and other healthcare facilities. It offers interior air sterilization and disinfection products for the eradication of harmful airborne pathogens, including COVID-19. It provides Purgo, an air filtration machine; and Purgo Lift, an air purification solution for elevators and other wall-mount applications. The company was formerly known as AeroClean Technologies, LLC. AeroClean Technologies, Inc. was founded in 2011 and is headquartered in Palm Beach Gardens, Florida.